Icure Pharmaceutical Incorporation Past Earnings Performance
Past criteria checks 0/6
Icure Pharmaceutical Incorporation's earnings have been declining at an average annual rate of -35.6%, while the Personal Products industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 3.2% per year.
Key information
-35.6%
Earnings growth rate
-26.0%
EPS growth rate
| Personal Products Industry Growth | 3.8% |
| Revenue growth rate | 3.2% |
| Return on equity | -54.2% |
| Net Margin | -55.3% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Icure Pharmaceutical Incorporation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 56,806 | -31,420 | 21,184 | 3,685 |
| 30 Sep 23 | 59,572 | -34,678 | 15,085 | 3,850 |
| 30 Jun 23 | 61,356 | -38,135 | 15,322 | 3,884 |
| 31 Mar 23 | 61,369 | -42,040 | 14,864 | 4,553 |
| 31 Dec 22 | 59,367 | -41,766 | 13,554 | 4,242 |
| 30 Sep 22 | 59,239 | -38,067 | 13,821 | 3,707 |
| 30 Jun 22 | 56,894 | -41,963 | 15,200 | 3,193 |
| 31 Mar 22 | 60,940 | -40,690 | 17,089 | 2,261 |
| 31 Dec 21 | 64,283 | -38,167 | 20,004 | 2,419 |
| 30 Sep 21 | 70,224 | -29,807 | 25,226 | 2,656 |
| 30 Jun 21 | 76,826 | -20,638 | 28,000 | 2,807 |
| 31 Mar 21 | 83,550 | -15,083 | 27,622 | 3,099 |
| 31 Dec 20 | 90,144 | -12,614 | 27,790 | 3,046 |
| 30 Sep 20 | 87,504 | -19,684 | 25,291 | 2,258 |
| 30 Jun 20 | 86,905 | -15,143 | 24,022 | 2,068 |
| 31 Mar 20 | 77,452 | -9,153 | 24,132 | 2,099 |
| 31 Dec 19 | 60,922 | -8,751 | 21,156 | 1,685 |
| 30 Sep 19 | 49,822 | 4,978 | 18,270 | 2,889 |
| 30 Jun 19 | 37,867 | -1,848 | 17,313 | 2,793 |
| 31 Mar 19 | 31,479 | -11,411 | 17,253 | 2,119 |
| 31 Dec 18 | 33,320 | -7,885 | 17,539 | 2,090 |
| 30 Sep 18 | 36,227 | -6,647 | 16,464 | 1,156 |
| 30 Jun 18 | 40,747 | -3,916 | 16,156 | 859 |
| 31 Mar 18 | 40,230 | 2,704 | 13,378 | 640 |
| 31 Dec 17 | 39,796 | 538 | 12,263 | 599 |
| 30 Sep 17 | 37,952 | -813 | 11,417 | 620 |
| 30 Jun 17 | 32,964 | -1,231 | 8,000 | 691 |
| 31 Mar 17 | 30,189 | -2,889 | 7,544 | 879 |
| 31 Dec 16 | 27,279 | -3,243 | 6,932 | 871 |
| 30 Sep 16 | 23,914 | -3,367 | 5,895 | 898 |
| 30 Jun 16 | 19,517 | -3,811 | 5,241 | 849 |
| 31 Mar 16 | 17,967 | -3,301 | 4,614 | 807 |
| 31 Dec 15 | 18,673 | -2,878 | 3,875 | 670 |
| 31 Dec 14 | 14,930 | 958 | 1,009 | 218 |
Quality Earnings: A175250 is currently unprofitable.
Growing Profit Margin: A175250 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A175250 is unprofitable, and losses have increased over the past 5 years at a rate of 35.6% per year.
Accelerating Growth: Unable to compare A175250's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A175250 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (38.8%).
Return on Equity
High ROE: A175250 has a negative Return on Equity (-54.2%), as it is currently unprofitable.